仙乐健康（300791.SZ） 冲刺A+H双上市

Core Viewpoint - Xianle Health Technology Co., Ltd. has submitted an application to list on the Hong Kong Stock Exchange, with CITIC Securities as the sole sponsor [1] Company Overview - Xianle Health is a leading provider of nutritional health food solutions, ranked third globally by revenue in the nutritional health food solutions market for 2024, and first in China [4] - The company is the second-largest global supplier of gummy and soft capsule-based nutritional health food solutions by revenue for 2024 [4] - Xianle Health has established a global business presence with integrated production bases, R&D centers, and supply chain networks, enabling it to provide end-to-end solutions to global clients [4] Financial Performance - Revenue increased from RMB 3,582.0 million in 2023 to RMB 4,211.1 million in 2024, representing a growth of 17.6% [5] - Revenue for the nine months ending September 30, 2024, rose by 8.0% from RMB 3,048.5 million to RMB 3,291.2 million for the same period in 2025 [5] - Gross profit grew from RMB 1,062.1 million in 2023 to RMB 1,288.9 million in 2024, a 21.3% increase [6] - For the nine months ending September 30, 2024, gross profit increased by 11.7% from RMB 927.0 million to RMB 1,035.9 million for the same period in 2025 [6] - Net profit figures for 2023, 2024, and the nine months ending September 30 for 2024 and 2025 were RMB 240.3 million, RMB 282.0 million, RMB 212.7 million, and RMB 55.5 million respectively [6] - Adjusted net profit (non-IFRS) for the same periods were RMB 242.0 million, RMB 287.3 million, RMB 222.5 million, and RMB 216.1 million respectively [6]